RECQL and cancer: Importantly, while genetic alterations reducing the activity of RECQ1 have been shown to increase susceptibility to certain types of cancer, overexpression of RECQ1 has been associated with increased replication stress survival, drug resistance, and overall poor prognosis in patients with multiple myeloma.